No worries BW, I appreciate hearing other...

No worries BW, I appreciate hearing other viewpoints/perspectives, but I'll stick up for the majority of good pharmacy professionals all day long.

I am not all that happy with Sigmas performance either and some of the poor decisions made in the past (e.g. paid too much for Arrow). In this industry debt levels should be less with growth being self funded to a greater extent. Time will tell if the most recent aquisition will meet expectations. The product portfolio they aquired from BMS is pretty tired. The manufacturing plant adds capacity though and should be in good nick knowing the way BMS operate globally. I think the price actually is a bargain.

However, I think Sigma are the best positioned of all the Australian based pharmas to make the most of the growth that will come from out aging population.

Funny that you work in the mining industry and have an interests in the pharmaceutical Industry and I am visa versa.